Chemopreventive and immunomodulatory effects of Murraya koenigii aqueous extract on 4T1 breast cancer cell-challenged mice

Table 1 Tumor incidence and tumor burden at day 21 post 4T1 injection

Groups	Day 3		Day 7		Day 10		Day 14		Day 18		Day 21
Groups	TI	TB (%)	TI	TB (%)	TI	TB (%)	TI	TB (%)	TI	TB (%)	TI	TB (%)
Normal	-	-	-	-	-	-	-	-	-	-	-	-
LR untreated	0/6	0.00	0/6	0.00	4/6	0.10	6/6	0.42	6/6	1.00	6/6	2.11
LR MK 50 mg/kg	0/6	0.00	0/6	0.00	0/6	0.00	5/6	0.10	6/6	0.55	6/6	0.82
LR MK 200 mg/kg	0/6	0.00	0/6	0.00	0/6	0.00	0/6	0.00	5/6	0.20	6/6	0.36
HR untreated	4/6	0.03	6/6	0.33	6/6	0.84	6/6	1.30	6/6	2.11	6/6	3.65
HR MK 50 mg/kg	0/6	0.00	4/6	0.00	6/6	0.43	6/6	0.57	6/6	1.72	6/6	3.61
HR MK 200 mg/kg	0/6	0.00	0/6	0.00	4/6	0.05	5/6	0.26	6/6	0.84	6/6	2.23

ISSN: 2662-7671